Literature DB >> 16297863

NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method.

Henry Ogbomo1, Anke Hahn, Janina Geiler, Martin Michaelis, Hans Wilhelm Doerr, Jindrich Cinatl.   

Abstract

The measurement of natural killer (NK) cells toxicity against tumor or virus-infected cells especially in cases with small blood samples requires highly sensitive methods. Here, a coupled luminescent method (CLM) based on glyceraldehyde-3-phosphate dehydrogenase release from injured target cells was used to evaluate the cytotoxicity of interleukin-2 activated NK cells against neuroblastoma cell lines. In contrast to most other methods, CLM does not require the pretreatment of target cells with labeling substances which could be toxic or radioactive. The effective killing of tumor cells was achieved by low effector/target ratios ranging from 0.5:1 to 4:1. CLM provides highly sensitive, safe, and fast procedure for measurement of NK cell activity with small blood samples such as those obtained from pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297863     DOI: 10.1016/j.bbrc.2005.11.025

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.

Authors:  Henry Ogbomo; Janina Geiler; Anke Leutz; Kristina von Kietzell; Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-10-08       Impact factor: 3.402

2.  Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.

Authors:  Nidale Tarek; Jean-Benoit Le Luduec; Meighan M Gallagher; Junting Zheng; Jeffrey M Venstrom; Elizabeth Chamberlain; Shakeel Modak; Glenn Heller; Bo Dupont; Nai-Kong V Cheung; Katharine C Hsu
Journal:  J Clin Invest       Date:  2012-08-06       Impact factor: 14.808

3.  Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.

Authors:  Sara J Conry; Qinglai Meng; Gareth Hardy; Nicole L Yonkers; Julia M Sugalski; Amy Hirsch; Perica Davitkov; Anita Compan; Yngve Falck-Ytter; Ronald E Blanton; Benigno Rodriguez; Clifford V Harding; Donald D Anthony
Journal:  J Infect Dis       Date:  2012-02-20       Impact factor: 5.226

4.  Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.

Authors:  Henry Ogbomo; Martin Michaelis; Denise Klassert; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic HCV infection.

Authors:  Qinglai Meng; M R Sandhya Rani; Julia M Sugalski; Chelsey J Judge; Sarah Phat; Benigno Rodriguez; Ronald E Blanton; Donald D Anthony
Journal:  J Infect Dis       Date:  2013-12-02       Impact factor: 5.226

6.  Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study.

Authors:  Shakeel Modak; Jean-Benoit Le Luduec; Irene Y Cheung; Debra A Goldman; Irina Ostrovnaya; Ekaterina Doubrovina; Ellen Basu; Brian H Kushner; Kim Kramer; Stephen S Roberts; Richard J O'Reilly; Nai-Kong V Cheung; Katharine C Hsu
Journal:  Oncoimmunology       Date:  2018-05-10       Impact factor: 8.110

7.  A functional role for ADAM10 in human immunodeficiency virus type-1 replication.

Authors:  Brian M Friedrich; James L Murray; Guangyu Li; Jinsong Sheng; Thomas W Hodge; Donald H Rubin; William A O'Brien; Monique R Ferguson
Journal:  Retrovirology       Date:  2011-05-11       Impact factor: 4.602

8.  Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells.

Authors:  Jonathan P H Fisher; Mengyong Yan; Jennifer Heuijerjans; Lisa Carter; Ayda Abolhassani; Jennifer Frosch; Rebecca Wallace; Barry Flutter; Anna Capsomidis; Mike Hubank; Nigel Klein; Robin Callard; Kenth Gustafsson; John Anderson
Journal:  Clin Cancer Res       Date:  2014-06-03       Impact factor: 12.531

9.  Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.

Authors:  Henry Ogbomo; Franz J Zemp; Xueqing Lun; Jiqing Zhang; Danuta Stack; Masmudur M Rahman; Grant McFadden; Christopher H Mody; Peter A Forsyth
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

10.  Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.

Authors:  Marijke van Rikxoort; Martin Michaelis; Markus Wolschek; Thomas Muster; Andrej Egorov; Joachim Seipelt; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.